Pediatric Flu Vaccine – 2025-2026
Award Notice Posted
- Solicitation number
- 75D301-25-D-20402
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Awarded
- to Glaxosmithkline, LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75D301-25-D-20402 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Atlanta, Georgia 30341, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services has awarded contract 75D301-25-D-20402 to GlaxoSmithKline, LLC for pediatric flu vaccine procurement for the 2025-2026 season. The contract was awarded on December 30, 2024, with a total value of $182,592,000.00. This civilian agency contract appears to be a significant procurement for pediatric influenza immunization, covering vaccine supplies for the upcoming flu season without any specific set-aside restrictions.
Notice text
Awarded contract 75D301-25-D-20402 to GLAXOSMITHKLINE, LLC for 182592000.00 on 2024-12-30.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Pediatric Flu Vaccine – 2025-2026 | Award Notice | |
| Pediatric Flu Vaccine – 2025-2026 | Award Notice | |
| This notice | Award Notice | |
| Pediatric Flu Vaccine – 2025-2026 | Award Notice | |
| Pediatric Flu Vaccine – 2025-2026 | Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response | Office of the Assistant Secretary for Preparedness and Response | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity